{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:53:18Z","timestamp":1776775998166,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13048-019-0554-9","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:30:04Z","timestamp":1567164604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Samira","family":"Behboudi-Gandevani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayedeh","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Tohidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-7827-9-39","volume":"9","author":"FR Tehrani","year":"2011","unstructured":"Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39.","journal-title":"Reprod Biol Endocrinol"},{"key":"554_CR2","first-page":"1","volume":"6","author":"SM Sirmans","year":"2014","unstructured":"Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014;6:1\u201313.","journal-title":"Clin Epidemiol"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/09513590.2015.1117069","volume":"32","author":"S Behboudi-Gandevani","year":"2016","unstructured":"Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M, et al. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32:343\u201353.","journal-title":"Gynecol Endocrinol"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/cen.13477","volume":"88","author":"S Behboudi-Gandevani","year":"2018","unstructured":"Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Noroozzadeh M, Farahmand M, Rostami Dovom M, et al. The risk of metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Clin Endocrinol. 2018;88:169\u201384.","journal-title":"Clin Endocrinol"},{"key":"554_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168402","volume":"11","author":"M Rostami Dovom","year":"2016","unstructured":"Rostami Dovom M, Ramezani Tehrani F, Djalalinia S, Cheraghi L, Behboudi Gandavani S, Azizi F. Menstrual cycle irregularity and metabolic disorders: a population-based prospective study. PLoS One. 2016;11:e0168402.","journal-title":"PLoS One"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1757-2215-7-18","volume":"7","author":"SS Mirza","year":"2014","unstructured":"Mirza SS, Shafique K, Shaikh AR, Khan NA, Anwar QM. Association between circulating adiponectin levels and polycystic ovarian syndrome. J Ovarian Res. 2014;7:18.","journal-title":"J Ovarian Res"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.fertnstert.2017.09.004","volume":"108","author":"H Kazemi Jaliseh","year":"2017","unstructured":"Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, et al. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. 2017;108:1078\u201384.","journal-title":"Fertil Steril"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/cen.13389","volume":"87","author":"M Amiri","year":"2017","unstructured":"Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis. Clin Endocrinol. 2017;87:217\u201330.","journal-title":"Clin Endocrinol"},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40618-017-0650-x","volume":"40","author":"S Behboudi-Gandevani","year":"2017","unstructured":"Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Investig. 2017;40:859\u201366.","journal-title":"J Endocrinol Investig"},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3109\/09513590.2014.943725","volume":"30","author":"N Mendoza","year":"2014","unstructured":"Mendoza N, Simoncini T, Genazzani AD. Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies. Gynecol Endocrinol. 2014;30:850\u201360.","journal-title":"Gynecol Endocrinol"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/jc.2014-3196","volume":"100","author":"BO Yildiz","year":"2015","unstructured":"Yildiz BO. Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100:794\u2013802.","journal-title":"J Clin Endocrinol Metab"},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2265.2012.04466.x","volume":"78","author":"A Harmanci","year":"2013","unstructured":"Harmanci A, Cinar N, Bayraktar M, Yildiz BO. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clin Endocrinol. 2013;78:120\u20135.","journal-title":"Clin Endocrinol"},{"key":"554_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/OAJC.S85543","volume":"8","author":"AS de Melo","year":"2017","unstructured":"de Melo AS, Dos Reis RM, Ferriani RA, Vieira CS. Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits. Open Access J Contracept. 2017;8:13\u201323.","journal-title":"Open Access J Contracept"},{"key":"554_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/1354750X.2019.1620335","volume":"24","author":"RE Tiongco","year":"2019","unstructured":"Tiongco RE, Rivera N, Clemente B, Dizon D, Salita C, Pineda-Cortel MR. Serum ferritin as a candidate diagnostic biomarker of polycystic ovarian syndrome: a meta-analysis. Biomarkers. 2019;24:484\u201391.","journal-title":"Biomarkers"},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tem.2012.04.003","volume":"23","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF. Iron metabolism and the polycystic ovary syndrome. Trends Endocrinol Metab. 2012;23:509\u201315.","journal-title":"Trends Endocrinol Metab"},{"key":"554_CR16","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.2337\/diacare.28.8.2042","volume":"28","author":"HF1 Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF1, Luque-Ram\u00edrez M, Alvarez-Blasco F, Botella-Carretero JI, Sancho J, San Mill\u00e1n JL. Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care. 2005;28:2042\u20134.","journal-title":"Diabetes Care"},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.2337\/dc07-0642","volume":"30","author":"M Luque-Ram\u00edrez","year":"2007","unstructured":"Luque-Ram\u00edrez M, Alvarez-Blasco F, Botella-Carretero JI, Sanch\u00f3n R, San Mill\u00e1n JL, Escobar-Morreale HF. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care. 2007;30:2309\u201313.","journal-title":"Diabetes Care"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molmet.2016.10.006","volume":"6","author":"L Stechemesser","year":"2016","unstructured":"Stechemesser L, Eder SK, Wagner A, Patsch W, Feldman A, Strasser M, et al. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. Mol Metab. 2016;6:38\u201347.","journal-title":"Mol Metab"},{"key":"554_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1741-7015-10-54","volume":"10","author":"KS Houschyar","year":"2012","unstructured":"Houschyar KS, L\u00fcdtke R, Dobos GJ, Kalus U, Broecker-Preuss M, Rampp T, et al. Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC Med. 2012;10:54.","journal-title":"BMC Med"},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1572-0241.2007.01192.x","volume":"102","author":"L Valenti","year":"2007","unstructured":"Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007;102:1251\u20138.","journal-title":"Am J Gastroenterol"},{"key":"554_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1741-7015-10-119","volume":"10","author":"W Bao","year":"2012","unstructured":"Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 2012;10:119.","journal-title":"BMC Med"},{"key":"554_CR22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","volume":"89","author":"NF Olivieri","year":"1997","unstructured":"Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739\u201361.","journal-title":"Blood"},{"key":"554_CR23","first-page":"478","volume":"77","author":"K Dmochowski","year":"1993","unstructured":"Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab. 1993;77:478\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/dc07-0939","volume":"31","author":"F Equitani","year":"2008","unstructured":"Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, et al. Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. Diabetes Care. 2008;31:3\u20138.","journal-title":"Diabetes Care"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.2337\/diacare.25.12.2249","volume":"25","author":"JM Fern\u00e1ndez-Real","year":"2002","unstructured":"Fern\u00e1ndez-Real JM, Pe\u00f1arroja G, Castro A, Garc\u00eda-Bragado F, L\u00f3pez-Bermejo A, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care. 2002;25:2249\u201355.","journal-title":"Diabetes Care"},{"key":"554_CR26","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejogrb.2013.09.029","volume":"172","author":"S Hashemi","year":"2014","unstructured":"Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol. 2014;172:51\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"554_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1476-511X-9-52","volume":"9","author":"Y Chen","year":"2010","unstructured":"Chen Y, Zhang X, Pan B, Jin X, Yao H, Chen B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010;9:52.","journal-title":"Lipids Health Dis"},{"key":"554_CR29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/clinchem\/33.8.1372","volume":"33","author":"TJ Wilke","year":"1987","unstructured":"Wilke TJ, Utley DJ. Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin. Clin Chem. 1987;33:1372\u20135.","journal-title":"Clin Chem"},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2337\/diabetes.51.4.1000","volume":"51","author":"JM Fern\u00e1ndez-Real","year":"2000","unstructured":"Fern\u00e1ndez-Real JM, Pe\u00f1arroja G, Castro A, Garc\u00eda-Bragado F, Hern\u00e1ndez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes. Effects on Insulin Sensitivity and \u03b2-Cell Function. Diabetes. 2000;51:1000\u20134.","journal-title":"Diabetes"},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13625187.2017.1317735","volume":"22","author":"X Ruan","year":"2017","unstructured":"Ruan X, Kubba A, Aguilar A, Mueck AO. Use of cyproterone acetate\/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects. Eur J Contracept Reprod Health Care. 2017;22:183\u201390.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00404-010-1790-9","volume":"284","author":"F Gode","year":"2011","unstructured":"Gode F, Karagoz C, Posaci C, Saatli B, Uysal D, Secil M, et al. Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol\u2013cyproterone acetate. Arch Gynecol Obstet. 2011;284:923\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","volume":"53","author":"CL1 Shufelt","year":"2009","unstructured":"Shufelt CL1, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53:221\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"554_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/01.CIR.103.1.52","volume":"103","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation. 2001;103:52\u20137.","journal-title":"Circulation"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2337\/dc09-0420","volume":"32","author":"MA Mart\u00ednez-Garc\u00eda","year":"2009","unstructured":"Mart\u00ednez-Garc\u00eda MA, Luque-Ram\u00edrez M, San-Mill\u00e1n JL, Escobar-Morreale HF. Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance and genomic variants related to inflammation, oxidative stress and iron metabolism. Diabetes Care. 2009;32:1525\u201330.","journal-title":"Diabetes Care"},{"key":"554_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003547","volume":"3","author":"R Brudevold","year":"2008","unstructured":"Brudevold R, Hole T, Hammerstr\u00f8m J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS One. 2008;3:e3547.","journal-title":"PLoS One"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.2337\/dc06-2625","volume":"30","author":"S Swaminathan","year":"2007","unstructured":"Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care. 2007;30:1926\u201333.","journal-title":"Diabetes Care"},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s00125-012-2633-y","volume":"55","author":"J Montonen","year":"2012","unstructured":"Montonen J, Boeing H, Steffen A, Lehmann R, Fritsche A, Joost H, et al. Body iron stores and risk of type 2 diabetes: results from the European prospective investigation into Cancer and nutrition (EPIC)-Potsdam study. Diabetologia. 2012;55:2613\u201321.","journal-title":"Diabetologia"},{"key":"554_CR39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/0026-0495(94)90204-6","volume":"43","author":"C Bofill","year":"1994","unstructured":"Bofill C, Joven J, Bages J, Vilella E, Sans T, Cavall\u00e9 P, et al. Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism. 1994;43:614\u201320.","journal-title":"Metabolism"},{"key":"554_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1210\/jc.2010-2211","volume":"96","author":"M Luque-Ram\u00edrez","year":"2011","unstructured":"Luque-Ram\u00edrez M, \u00c1lvarez-Blasco F, Alpa\u00f1\u00e9s M, Escobar-Morreale HF. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96:846\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"554_CR41","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/ijo.2008.154","volume":"32","author":"A Lecube","year":"2008","unstructured":"Lecube A, Hern\u00e1ndez C, Pelegr\u00ed D, Sim\u00f3 R. Factors accounting for high ferritin levels in obesity. Int J Obes. 2008;32:1665\u20139.","journal-title":"Int J Obes"},{"key":"554_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/er.2004-0004","volume":"26","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, San Mill\u00e1n JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26:251\u201382.","journal-title":"Endocr Rev"},{"key":"554_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/jc.2002-030024","volume":"89","author":"J Skrha","year":"2004","unstructured":"Skrha J, Haas T, Sindelka G, Pr\u00e1zn\u00fd M, Widimsk\u00fd J, Cibula D, et al. Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. J Clin Endocrinol Metab. 2004;89:135\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"554_CR44","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1210\/jc.2007-2656","volume":"93","author":"MA Lawson","year":"2008","unstructured":"Lawson MA, Jain S, Sun S, Patel K, Malcolm PJ, Chang RJ. Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women. J Clin Endocrinol Metab. 2008;93:2089\u201396.","journal-title":"J Clin Endocrinol Metab"},{"key":"554_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92:405\u201313.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0554-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-019-0554-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-019-0554-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:12:52Z","timestamp":1598656372000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-019-0554-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/s13048-019-0554-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"23 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee affiliated with the Research Institute for Endocrine Sciences. It also was registered and approved on the Iranian Registry of Clinical Trials under the code of IRCT2013080514277N1. A written informed consent was obtained from the women with PCOS before the initiation of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}